[Clonal evolution in acute myeloblastic leukemia in a trisomic 21 child].
D000970:Antineoplastic Agents / Q000494:pharmacology; D001854:Bone Marrow Cells; D002904:Chromosomes, Human, 21-22 and Y; D002999:Clone Cells; D004314:Down Syndrome / Q000097:blood / Q000150:complications* / Q000235:genetics / Q000473:pathology; D006801:Humans; D007223:Infant; D007621:Karyotyping; D037102:Lectins / Q000494:pharmacology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000150:complications* / Q000235:genetics / Q000473:pathology; D008297:Male; D008938:Mitosis / Q000187:drug effects; D012641:Selection, Genetic; D013997:Time Factors; D014314:Trisomy
D000970:Antineoplastic Agents; D037102:Lectins
Evolution clonale au cours d'une leucéme aiguë myéloblastique chez un enfant trisomique 21.